In order to ensure a widespread distribution in the lung and to avoid the effect of anesthesia, bleomycin at a total dose of 4.5 or 6.0 mg/kg was administered in four divided doses (0.5 ml/kg/time) at intervals of 2 h to male rats via a catheter (tracheotomy tube) without anesthesia. In comparison to vehicle (saline) controls, bleomycin-treated rats showed a significant suppression of body weight gain that was observed transiently at 4.5 mg/kg and continuously (throughout the 3-week observation period) at 6.0 mg/kg. Histopathologically, interstitial pneumonitis, thickening of alveolar walls, thickening of pulmonary arterial walls, foamy cells in alveoli, and hemorrhage were observed in both 4.5 and 6 mg/kg groups, and also emphysema in the 6 mg/kg group. Both groups exhibited a significant decrease in the partial pressure of arterial oxygen (PaO 2 ) and a significant increase in alveolar-arterial oxygen tension difference (AaDO 2 ), and a significant increase in erythrocyte count was observed in the 6 mg/kg group. Furthermore, both treated groups showed a significant increase in the ratio of the right ventricular weight versus left ventricle plus septum weights. The significant increase in erythrocyte count might have been caused by diffusion disturbance and ventilation-perfusion imbalance due to the pulmonary damage. These findings suggest that the present experimental method will be useful for clarification of the pulmonary damage induced by bleomycin in rats. Key words: bleomycin, catheter, diffusion disturbance, erythrocyte count, ventilationperfusion imbalance the precise mechanisms involved in the induction of this disease have not been clarified completely. In rodents, a single intratracheal administration under anesthesia is frequently used for preparing an animal model [7, 10, 23, 26, 32] , but the extent and severity of pulmonary damage caused by bleomycin varies considerably depending on the attainability of the drug solution [16] . Furthermore, anesthesia itself causes respiratory and
Introduction
Bleomycin is an antineoplastic agent, and is recognized to cause interstitial pneumonitis that can lead to fibrosis as a side effect during treatment in humans [2, 24] . This toxic effect of bleomycin has been utilized advantageously in a number of experimental approaches to pulmonary fibrosis in animal models [15] . However, cardiovascular depression [34] . Therefore, in some cases, intratracheal administration of bleomycin under anesthesia induces death by respiratory failure (suffocation) during the dosing. Although intraperitoneal administration has been used [16, 28] to avoid the disadvantages of the intratracheal administration, this method needs a longer duration for induction of pulmonary fibrosis.
In the present experiment, therefore, a small amount of bleomycin was slowly administered in four divided doses at intervals of 2 h to rats via a catheter (tracheotomy tube) without anesthesia. This would be able to ensure a widespread distribution of the drug in the lung and to avoid the effects of anesthesia during drug administration. Since earlier studies conducted in rodents have mainly focused on the morphologic and/or biochemical aspects [5, 11, 14, 28, 31] , we attempted to examine parameters of the blood gas and hematology in addition to body weight, organ weight, and histopathology.
Materials and Methods

Animals and treatment:
Six-week-old male Crj:CD (SD) IGS rats were purchased from Charles River Japan. The experimental schedule is summarized in Fig.  1 . The animal experiments were conducted according to the "Guide for the Care and Use of Laboratory Animals" of the Otsuka Pharmaceutical Company. Three days before drug administration, all rats were anesthetized with Ketamine-Diazepam by intraperitoneal injection [34] , and tracheotomy was surgically performed. A catheter (tracheotomy tube) consisting of two pieces of polyethylene tubing (PE 8: ID 0.2 mm, OD 0.5 mm and PE 35: ID 0.5 mm, OD 0.9 mm, NATSUME SEISAKUSHO, Co., Ltd., Japan) was inserted between the cartilaginous rings and placed in the trachea (PE8: 17 mm). Then, the catheter (PE 35) was subcutaneously tunneled to the nape of the neck. The catheter-implanted rats were divided into three groups of 10 rats (170-190 g): two treated groups and one vehicle control group. Bleomycin at a total dose of 4.5 or 6.0 mg/kg was administered in four divided doses (0.5 ml/kg/time) at intervals of 2 h to the rats via the catheter without anesthesia (the rats were held in the standing position, and were gradually and bilaterally tilted). Vehicle control animals were administered saline at the same volume in the same manner.
The rats were housed in pairs in polycarbonate cages (255 × 410 × 180 mm) with bedding of chips (SHEP-HERD SPECIALTY PAPERS) and maintained in a room controlled at 21-25°C and 50-70% relative humidity with a 12/12 h light/dark cycle. They had free access to food and water. Three weeks after the bleomycin administration (one day before necropsy), all rats were anesthetized with Ketamine-Diasepam by intraperitoneal injection, and polyethylene tubing (PE 35) was surgically implanted in the right carotid artery, and then subcutaneously tunneled to the nape of the neck in order to obtain arterial blood samples [29, 33] . The catheter was filled with a mixture of heparin (50 IU/ml) and polyvinylpyrrolidone (20 w/v%) in saline until the arterial blood sampling.
Bleomycin hydrochloride was purchased from Nippon Kayaku Co., Ltd. (Tokyo, Japan), and diluted with saline to prepare 0.3 or 0.225% solution. Ketamine hydrochloride and Diazepam (CERCINE ® INJECTUON) were obtained from Sankyo Yell Yakuhin (Pharmaceutical Products) Co., Ltd. (Tokyo, Japan) and Takeda Chemical Industries Ltd. (Osaka, Japan), respectively.
Body weight: All rats were measured three or four times per week. For calculation of organ-to-bodyweight (relative weight), all rats were measured on the day of necropsy.
Hematology: One day before necropsy (day 23) after fasting for 16 h or longer, approximately 1 ml of blood was collected from the left jugular vein from each rat without anesthesia [19] . Approximately 0.3 ml of each blood sample was used for determination of leukocyte each rat three days before dosing (day -3). All rats in treated groups received bleomycin after grouping on day 1. Blood samples for hematology (Hem.) and blood biochemistry (Bio.) were withdrawn from all rats on day 23. An arterial catheter was implanted in each rat on day 23, and arterial blood samples were withdrawn from the catheter on day 24. The rats were sacrificed on day 24.
(WBC), erythrocyte (RBC), reticulocyte, platelet (Plat) counts, hematocrit (Ht), hemoglobin concentration (Hb), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH) and mean corpuscular hemoglobin concentration (MCHC) (THMS H-1, TECHNICON), and the rest was used for serum total protein (TP) measurement (Hitachi 7170). The WBC count and ratio were classified as neutrophil (Neut), lymphocyte (Lym), monocyte (Mon), eosinophil (Eos), and basophil (Bas). Arterial blood gas: Arterial blood samples were withdrawn from the arterial catheter without anesthesia on the day of necropsy. Analysis for pH, arterial oxygen tension (PaO 2 ), and arterial carbon dioxide tension (PaCO 2 ), and calculation of arterial oxygen content (CaO 2 ) and alveolar-arterial oxygen tension difference (AaDO 2 ) were performed using a blood gas analyzer (CHIRON 248, Chiron Co., Ltd.). The body temperature was monitored using an electronic thermometer in order to correct the results of blood gas concentrations and pH analysis.
Organ weight and histopathology: After the arterial blood sampling for gas analysis, all animals were euthanized by exsanguination under deep anesthesia with ether. Immediately, the spleen, lungs, and heart were removed, weighed, and fixed in 10% neutral-buffered formalin. The femur and sternum were also fixed in the same fixative. After one-day fixation, the right ventricle (RV) and left ventricle plus septum (LV+S) were separated and weighed for calculation of the ratio of RV / (LV+S) [8] . Tissue sections were stained with hematoxylin-eosin (H&E) for all tissues, Masson Trichrome for the lungs, and Prussian Blue stain for the spleen, and examined by light microscopy.
Statistical analysis
One-way analysis of variance was used to analyze the data on body weight, blood gas, hematology, blood biochemistry, and organ weights. If one-way analysis of variance revealed a significant difference (p<0.05), then the values were analyzed using Dunnett's test. The paired t-test was used to compare the values of reticulocytes. All the analyses were performed by two-tailed tests and assessed for significance at levels of p<0.05 and p<0.01.
Results
Mortality:
No deaths occurred from day 1 (on the day of the intratracheal administration) until day 22.
Body weight: In comparison to the vehicle control group, the 4.5 mg/kg group showed a significant suppression of body weight gain from days 3 to 12, and significantly lower body weights from days 5 to 8. The 6 mg/kg group showed a significant suppression of body weight gain and significantly lower body weights from days 3 to 22 (Fig. 2) .
Hematology and blood biochemistry: In comparison to the vehicle control group, the 6 mg/kg group showed significant increases in erythrocyte and eosinophil counts. The 4.5 and 6 mg/kg groups also showed increases in eosinophil count and hematocrit value, respectively, but these increases were not statistically significant. In both groups, no significant change was observed in other hematological parameters. In comparison to the vehicle control group, no significant difference in total protein was observed in either treated group (Table 1) .
Arterial blood gas: In comparison to the vehicle control group, a significant decrease in PaO 2 and a significant increase in AaDO 2 were observed in the 4.5 and 6 mg/kg groups ( Table 2 ). In both treated groups, no significant change was observed in pH, PaCO 2 , or CaO 2 .
Organ weights: Increases in the absolute and relative weights of the lungs were observed in the 4.5 and 6 mg/kg groups, but were not statistically significant. In comparison to the vehicle control group, the 6 mg/kg Fig. 2 . Body weight change after intratracheal administration of bleomycin in rats. All values are given as mean ± SD for 10 rats in each group. *: p<0.05, **: p<0.01 ; significant differences from the vehicle control.
weight versus left ventricle plus septum weights [RV / (LV+S)]. No significant change in the absolute or relative weight of the spleen was observed in either treated group (Table 3) .
group showed a significant decrease in absolute weight of the heart, but it was not statistically significant in relative weight. The 4.5 and 6 mg/kg groups showed significant increases in the ratio of the right ventricular Histopathology: Interstitial pneumonitis, thickening of alveolar walls, foamy cells in alveoli, and hemorrhage were frequently observed in the 4.5 and 6 mg/kg groups (Table 4, Fig. 3 ). In addition, thickening of pulmonary arterial walls was noted in one or two animals in the treated groups. Furthermore, squamous metaplasia of bronchial epithelium was observed in one animal of the 4.5 mg/kg group, and emphysema in two animals of the 6 mg/kg group. No abnormalities were observed in the lungs of the vehicle control group. The spleen and bone marrow of all groups showed no abnormalities. 
Discussion
In agreement with previous reports [4, 23, 28] , a significant suppression of body weight gain was observed in the 4.5 and 6.0 mg/kg groups. However, there were no deaths on the day of dosing or during the 3-week observation period. In the lungs of the treated groups, interstitial pneumonitis, thickening of alveolar walls, thickening of pulmonary arterial walls, foamy cells in alveoli, and hemorrhage were observed. Squamous metaplasia of bronchial epithelium observed in the 4.5 mg/kg group was also considered to be an interstitial pneumonitis-related change [14] . In our previously conducted examination of a single intratracheal administration of bleomycin under anesthesia, emphysema was frequently observed which suggested local retention of the drug fluid. Emphysema was noted in only two animals in the 6 mg/kg group in the present examination, suggesting the drug fluid was widely distributed. No abnormalities were observed in the spleen or bone marrow in either dose group.
In both treated groups, a significant decrease in PaO 2 and a significant increase in AaDO 2 were observed. In the 6 mg/kg group, pulmonary damage was more frequent and the degree of the changes in arterial blood gas parameters was more apparent than those of the 4.5 mg/kg group. The significant increase in AaDO 2 indicates an impairment of pulmonary gas exchange, such as ventilation-perfusion inequality and/or diffusion impairment. It has been suggested that the histological changes such as interstitial pneumonitis and thickening of alveolar walls in bleomycin-administered lungs may cause an increase in pulmonary elastic recoil which results in diffusion disturbance and pulmonary vasoconstriction reduction [10] . Furthermore, the increase in pulmonary elastic recoil might induce thickening of arterial walls, finally resulting in hypertrophy of the right ventricle [30] . Right ventricular hypertrophy was evaluated and confirmed on the basis of RV/(LV+S) weight ratios [17] . All these impairments of pulmonary gas exchange could have caused the decrease in PaO 2 , and resulted in the increase in erythrocyte count and Ht as a reflex adaptation to the low-oxygen condition [3] . Therefore, the compensatory increase in erythrocyte count with the tendency of increasing Ht in the 6 mg/kg group resulted in the significant decrease in PaO 2 without significant decrease in CaO 2 .
Thickening of small pulmonary arteries and right ventricular hypertrophy have been produced by experimentally hypoxic conditions in rats [12] . It was reported that the rats subjected to alveolar hypoxia for several weeks in a hypoxic chamber developed sustained pulmonary hypertension with right ventricular hypertrophy, thickening of pulmonary arterial walls, and polycythemia [1, 21, 22, 25] . In general, increase in erythrocyte count is also inducible by hemoconcentration caused by decrease in food consumption [20] . Although food consumption was not determined in the present study due to the paired housing, there was no increase in the plasma protein concentration which suggests hemoconcentration is not a causative factor.
There was no significant change in reticulocyte count in the 6 mg/kg group. The reticulocyte response shows an early peak and gradually declines to near the control level for the duration of hypoxia [13, 18] , thus the reticulocyte might be in a recovery stage at 3 weeks after bleomycin administration. In the present study, an increase in eosinophil count was observed in both treated groups. Increases in eosinophil counts in the blood, lung tissue, and bronchoalveolar lavage fluid by intratracheal administration of bleomycin in rats have been reported [6, 27] , but the results are not well understood [9] .
In conclusion, intratracheal administration of bleomycin via a catheter in unanesthetized rats showed dose proportional changes suggesting that the present experimental method will be useful for clarification of the pulmonary damage induced by bleomycin in rats.
